December 27, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, and Mendaera, a Silicon Valley-based company developing technology to help healthcare providers more easily and confidently perform procedures through the power of medical robotics, today announced an agreement to commercialize a novel robotic system that is Powered by Butterfly’s Ultrasound-on-Chip technology. Upon commercialization, the deal includes revenue share for every unit sold.
Mendaera’s robotic technology is compatible with Butterfly’s proprietary semiconductor-based ultrasound device and connected via Butterfly’s software development kit – Butterfly Garden – creating a system designed to improve precision and consistency for a broad range of image-guided, needle-based interventions. This new category of robotics will increase access to high quality interventional treatment, ultimately aiming to streamline patient care within a healthcare system burdened by workforce shortages and burnout. Both companies anticipate FDA submission of the product by 2025.
“Mendaera’s robotic system is perfectly suited to leverage Butterfly’s proprietary Ultrasound-on-Chip by benefiting from the wide array of ultrasonic sensing applications that only our chip can offer,” said Darius Shahida, Chief Strategy Officer of Butterfly Network. “We are excited to welcome the Mendaera team as a Powered by Butterfly partner and believe our joint solution will expand Butterfly’s reach and clinical impact into the interventional space.”
“At Mendaera, we envision a world where high-quality intervention is available at every care facility, for each and every patient encounter. It was a clear choice for us to collaborate with Butterfly on our technology roadmap, given their unique and programmable Ultrasound-on-Chip platform and aligned mission to make ultrasonic imaging and intervention ubiquitous,” said Josh DeFonzo, Co-Founder and CEO of Mendaera.
The news follows Mendaera’s August 2023 announcement of securing $24 million in Series A Funding, led by Lux Capital, with participation from Founders Fund, Operator Partners, Allen & Company, and Parade Ventures. Mendaera has also announced completion of the research and design process for this novel robotic system.
For more information: https://www.butterflynetwork.com/butterfly-garden
February 13, 2024 
![With the addition of Pulse Wave Doppler [1], Philips has greatly expanded the utility of its Handheld Ultrasound – Lumify – enabling clinicians to quantify blood flow in a wide range of point-of-care diagnostic applications – including cardiology, vascular, abdominal, urology, obstetrics and gynecology.](/sites/default/files/styles/content_feed_medium/public/Screen%20Shot%202022-02-09%20at%209.23.01%20AM.png?itok=sb5JOa7n)
